A new indication for therapeutic drug monitoring in the neonate

Therapeutic Drug Monitoring

Volumn 28, Issue 1, 2006, Pages 1-

  Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN UPTAKE INHIBITOR; OPIATE; SEROTONIN UPTAKE INHIBITOR;

DIFFERENTIAL DIAGNOSIS; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; HUMAN; NEWBORN CARE; NOTE; PRIORITY JOURNAL; BLOOD; FEMALE; FETOMATERNAL TRANSFUSION; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; WITHDRAWAL SYNDROME;

DRUG MONITORING; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; SEROTONIN UPTAKE INHIBITORS;

EID: 33745513231     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000187973.02624.67     Document Type: Note

References (1)

1. Koren G, Matsui D, Einarson A, et al. Is maternal use of selective serotonin reuptake inhibitors in the third trimester harmful to neonates? Can Med Assoc J. 2005;172:1457-1459.